SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-24-005394
Filing Date
2024-08-09
Accepted
2024-08-09 09:05:02
Documents
1
Period of Report
2024-08-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1575
  Complete submission text file 0001683168-24-005394.txt   3168
Mailing Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752
Business Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Issuer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PHIO PHARMACEUTICALS CORP. 11 APEX DRIVE, SUITE 300A, PMB 2006 MARLBOROUGH MA 01752
Business Address
Infarinato Robert M. (Reporting) CIK: 0002032518 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36304 | Film No.: 241190567